Previous close | 2.9900 |
Open | 3.0100 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 3.0100 - 3.0100 |
52-week range | 2.8700 - 5.1900 |
Volume | |
Avg. volume | 6,011 |
Market cap | 6.021B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 6.14 |
EPS (TTM) | 0.4900 |
Earnings date | N/A |
Forward dividend & yield | 0.16 (5.25%) |
Ex-dividend date | 19 May 2022 |
1y target est | N/A |
B&Q owner Kingfisher has reported "resilient" trading in its latest quarter as supply chain troubles began to ease.
The expansion will create 800 new retail jobs.
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Wednesday May 11, 2022.